URL path: Index page // Blog // Scientific News // From Symptoms to Causes: 5 Tests That Are Changing Diagnosis
Blog
Scientific News
Scientific News
20-04-2026

From Symptoms to Causes: 5 Tests That Are Changing Diagnosis

Medical diagnosis is evolving rapidly. Until recently, health assessments were based primarily on standard blood tests and imaging. Today, the approach is shifting toward functional medicine, which focuses not only on the presence of disease but also on the underlying dysfunctions that precede its development. To understand the importance of these new tests, it is essential to clarify some key concepts:

  • The concept of a biomarker refers to measurable parameters of the body, such as hormones, metabolites, or microbial populations, that reflect physiological or pathological states.
  • Modern tests are not limited to simple values, but capture dynamic systems, such as the stress axis or the gut microbiome.
  • Functional medicine emphasizes the interconnection of systems. For example, the gut, the immune system, and the brain function as an integrated network. As a result, a symptom such as fatigue or mood disturbance may be linked to multiple mechanisms rather than a single cause.
  • The concept of personalized medicine is also a central pillar. Instead of general recommendations, treatment is based on each individual’s unique biological profile, as derived from specialized testing.

Recent studies show that parameters derived from microbiome analysis, along with biomarkers such as cortisol and the fatty acid profile (omega-3 and omega-6), can be used not only for diagnosis but also for risk prediction and therapeutic guidance, enhancing the precision of medical care. Within this context, new diagnostic tests are emerging that fundamentally change how we understand health and disease.

Why the Diagnostic Approach Is Changing Today
This shift is not accidental. It is driven by three main factors:

  • Technology now enables the analysis of complex biological data. For example, gut microbiome mapping can reveal imbalances that are not detectable through conventional tests.
  • Scientific understanding of the body’s systems has advanced significantly. The gut–brain–immune axis has become a major field of research, with direct clinical applications.
  • The need for prevention is greater than ever. Chronic diseases do not appear suddenly. They are preceded by years of functional imbalances that can be detected early.
     

What This Means for the Patient
In practical terms, this evolution means that:

  • Diagnosis can be made earlier. We no longer wait for severe symptoms to appear. Specialized biomarkers allow the detection of early deviations, enabling preventive intervention.
  • Symptoms are interpreted more comprehensively. A symptom such as chronic fatigue is not treated as an isolated issue, but analyzed in terms of hormones, inflammation, gut microbiome, and metabolism.
  • Treatment becomes more targeted. Instead of general recommendations, interventions are based on objective data, increasing effectiveness and reducing unnecessary medication use
Core Functional Medicine Tests

The modern diagnostic approach is shifting from simple disease detection to understanding the mechanisms that drive it. In this context, certain tests take on particular importance, as they reveal functional imbalances before they progress to clinical pathology.

  1. EnteroScan®: Gut Microbiome Analysis. Gut microbiome analysis is one of the most important advances in modern medicine. It evaluates the composition and function of microorganisms residing in the gut. The microbiome participates in the regulation of the immune system, inflammation, and metabolism, and is closely linked to the gut–brain axis. It records bacterial diversity, the presence of pathogens, and metabolites such as short-chain fatty acids. It can reveal dysbiosis even when conventional tests are normal, enabling targeted interventions.
  2. AdrenalScan®: Adrenal Function Assessment (Salivary Cortisol).Cortisol is a key biomarker of the hypothalamic–pituitary–adrenal axis. Measuring it in saliva reflects its fluctuations throughout the day. This allows evaluation of the circadian rhythm of cortisol and the function of the stress axis. It helps link symptoms such as fatigue and insomnia to specific biological imbalances.
  3. NutriScan®: Vitamin and Micronutrient Assessment. This is an advanced evaluation that assesses nutritional status and the functional adequacy of micronutrients beyond simple blood measurements. It includes a comprehensive assessment of vitamins and trace elements, measurement of markers of functional adequacy (not just circulating levels), and evaluation of cellular utilization of nutrients. This approach can reveal subclinical deficiencies that are not detected in basic testing. Symptoms such as fatigue, reduced concentration, frequent infections, or mood disturbances are often associated with such imbalances, allowing for more targeted nutritional and supplemental interventions.
  4. ImmuneScan®: Immune System Assessment. Low-grade chronic inflammation is a key mechanism underlying many diseases and is closely linked to immune function. This test is based on the combined analysis of inflammatory and immune markers. It enables the detection of subclinical inflammation and immune dysregulation at an early stage, even in the absence of clear symptoms. At the same time, it helps differentiate between different causes of inflammation and supports more targeted interventions.
  5. myGenomix®: Genetic Predisposition Testing. Genetic testing is a key tool in personalized medicine, as it reveals each individual’s biological predisposition. It analyzes polymorphisms related to vitamin and nutrient metabolism, inflammation, detoxification, and neuroendocrine regulation. It explains why individuals respond differently to diet, environment, and treatment, highlighting personalized needs. It guides more targeted interventions in nutrition, supplementation, and lifestyle, enhancing prevention.

The modern approach is to combine tests rather than evaluate isolated markers. The integration of microbiome, hormonal, micronutrient, and genetic data reveals functional patterns that are not visible through conventional testing. It transforms medicine into a preventive and personalized practice, focusing not only on what is happening, but also on why it is happening and in whom.

Biological Pathways and Functional Connections

Modern medicine is increasingly based on understanding interactions between systems rather than evaluating organs in isolation.

  • The gut–brain–immune axis is one of the most important biological networks. The gut microbiome influences inflammation, neurotransmission, and metabolism, while its disruption is associated with activation of the stress axis and elevated cortisol levels.
  • Cortisol, as a key regulator of the stress response, affects metabolism, immune function, and the microbiome. Chronic dysregulation can create a vicious cycle between stress, inflammation, and gut dysfunction.
  • A common underlying factor in these processes is low-grade chronic inflammation, which is associated with a wide range of chronic diseases and may arise from diet, stress, dysbiosis, or micronutrient deficiencies.
  • Fatty acids, particularly the balance between omega-3 and omega-6, directly influence inflammation, brain function, and the microbiome, acting as key modulators of these systems.
  • Genetic factors add another layer of understanding, as they influence metabolism, inflammation, detoxification, and response to diet, explaining individual variability.

Within this framework, the shift from isolated findings to functional patterns is crucial. Combinations such as dysbiosis, elevated cortisol, fatty acid imbalance, and inflammation alongside genetic predisposition provide a more complete explanation of symptoms.

In Conclusion -From Diagnosis to Prevention

The most significant shift is not technological, but philosophical. The tests transforming diagnosis are not simply more advanced; they are part of a new medical model in which understanding precedes treatment and prevention precedes disease.

Modern testing enables the detection of functional imbalances, such as mild inflammation or microbiome disruption, long before symptoms appear. At the same time, treatment is no longer based on general recommendations, but on data specific to the individual, including genetic characteristics. In this context, health is no longer defined as the absence of symptoms, but as a dynamic balance between systems. This balance can be measured, evaluated, and improved with the appropriate tools.

Early intervention can reduce the risk of cardiometabolic, autoimmune, and neurodegenerative diseases. Choosing the right tests at the right time may be the first and most important step toward a more comprehensive and conscious approach to health.

References
  1. Zinkow, A., Grodzicki, W., Czerwińska, M., & Dziendzikowska, K. (2025). Molecular Mechanisms Linking Omega-3 Fatty Acids and the Gut–Brain Axis. Molecules, 30(1), 71. https://doi.org/10.3390/molecules30010071
  2. De Cillis, F., Begni, V., Genini, P., Leo, D., Riva, M. A., & Cattaneo, A. (2025). Restoring Balance: The Role of Omega-3 Polyunsaturated Fatty Acids on the Gut–Brain Axis and Other Interconnected Biological Pathways to Improve Depression. Nutrients, 17(21), 3426. https://doi.org/10.3390/nu17213426
  3. Bautista J, Hidalgo-Tinoco C, Di Capua Delgado M, Viteri-Recalde J, Guerra-Guerrero A and López-Cortés A (2025) The gut–brain–circadian axis in anxiety and depression: a critical review. Front. Psychiatry 16:1697200. doi: 10.3389/fpsyt.2025.1697200
  4. Merino del Portillo, M., Clemente-Suárez, V. J., Ruisoto, P., Jimenez, M., Ramos-Campo, D. J., Beltran-Velasco, A. I., Martínez-Guardado, I., Rubio-Zarapuz, A., Navarro-Jiménez, E., & Tornero-Aguilera, J. F. (2024). Nutritional Modulation of the Gut–Brain Axis: A Comprehensive Review of Dietary Interventions in Depression and Anxiety Management. Metabolites, 14(10), 549. https://doi.org/10.3390/metabo14100549
  5. Yassin LK, Skrabulyte-Barbulescu J, Alshamsi SH, Saeed S, Alkuwaiti SH, Almazrouei S, Alnuaimi A, BaniYas S, Aldhaheri D, Alderei M, Shehab S, Hamad MIK. The microbiota-gut-brain axis in mental and neurodegenerative disorders: opportunities for prevention and intervention. Front Aging Neurosci. 2025 Oct 1;17:1667448. doi: 10.3389/fnagi.2025.1667448. PMID: 41104042; PMCID: PMC12521449.
  6. Dziedzic, A., Maciak, K., Bliźniewska-Kowalska, K., Gałecka, M., Kobierecka, W., & Saluk, J. (2024). The Power of Psychobiotics in Depression: A Modern Approach through the Microbiota–Gut–Brain Axis: A Literature Review. Nutrients, 16(7), 1054. https://doi.org/10.3390/nu16071054
  7. Warren A, Nyavor Y, Beguelin A, Frame LA. Dangers of the chronic stress response in the context of the microbiota-gut-immune-brain axis and mental health: a narrative review. Front Immunol. 2024 May 2;15:1365871. doi: 10.3389/fimmu.2024.1365871. PMID: 38756771; PMCID: PMC11096445.
  8. Randeni, N., & Xu, B. (2025). Critical Review of the Cross-Links Between Dietary Components, the Gut Microbiome, and Depression. International Journal of Molecular Sciences, 26(2), 614. https://doi.org/10.3390/ijms26020614
  9. Kurhaluk, N., Kamiński, P., Bilski, R., Kołodziejska, R., Woźniak, A., & Tkaczenko, H. (2025). Role of Antioxidants in Modulating the Microbiota–Gut–Brain Axis and Their Impact on Neurodegenerative Diseases. International Journal of Molecular Sciences, 26(8), 3658. https://doi.org/10.3390/ijms26083658
  10. Borrego-Ruiz, A., & Borrego, J. J. (2026). Influence of the Gut-Brain Axis on Psychiatric Comorbidity in Inflammatory Bowel Disease. Psychiatry International, 7(2), 52. https://doi.org/10.3390/psychiatryint7020052
Share it